GLENN P MUIR Insider Trading
Get free email notifications about insider trading for GLENN P MUIR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GLENN P MUIR. GLENN P MUIR is a Director in REPLIGEN CORP ($RGEN) and a Director in Neuronetics, Inc. ($STIM) and a in G1 Therapeutics, Inc. ($GTHX) and a Director in G1 Therapeutics, Inc. ($GTHX) and a Director in ReWalk Robotics Ltd. ($RWLK).
Companies in which GLENN P MUIR is an Insider
G1 Therapeutics, Inc.
Trading Symbol: GTHXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of GLENN P MUIR:
Holdings: 170,969 shares
Latest Transaction: Nov 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Neuronetics, Inc.
Trading Symbol: STIMIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of GLENN P MUIR: Director
Holdings: 82,236 shares
Latest Transaction: Aug 07 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
REPLIGEN CORP
Trading Symbol: RGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of GLENN P MUIR: Director
Holdings: 5,905 shares
Current Value: $172,662
Latest Transaction: May 19 2020
$RGEN Market Capitalization: $984.14M
$RGEN Previous Close: $29.24
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ReWalk Robotics Ltd.
Trading Symbol: RWLKIndustry: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
Position of GLENN P MUIR: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 29 2017
$RWLK Market Capitalization: $35.12M
$RWLK Previous Close: $2.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of GLENN P MUIR
Sentiment: All, GTHX, STIM, RGEN, RWLK
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 19 2020 | GTHX | G1 Therapeutics, I ... | MUIR GLENN P | Buy | P | 13.50 | 50,000 | 675,000 | 170,969 | 121 K to 171 K (+41.33 %) | |
Nov 19 2020 | GTHX | G1 Therapeutics, I ... | MUIR GLENN P | Buy | P | 13.50 | 50,000 | 675,000 | 170,969 | 121 K to 171 K (+41.33 %) | |
Aug 07 2020 | STIM | Neuronetics, Inc. | MUIR GLENN P | Director | Grant | A | 0.00 | 18,513 | 0 | 82,236 | 63.7 K to 82.2 K (+29.05 %) |
Jun 12 2020 | GTHX | G1 Therapeutics, I ... | MUIR GLENN P | Director | Option Exercise | A | 17.59 | 20,000 | 351,800 | 20,000 | |
May 28 2020 | STIM | Neuronetics, Inc. | MUIR GLENN P | Director | Grant | A | 0.00 | 20,000 | 0 | 63,723 | 43.7 K to 63.7 K (+45.74 %) |
May 28 2020 | STIM | Neuronetics, Inc. | MUIR GLENN P | Director | Grant | A | 0.00 | 20,000 | 0 | 63,723 | 43.7 K to 63.7 K (+45.74 %) |
May 19 2020 | RGEN | REPLIGEN CORP | MUIR GLENN P | Director | Option Exercise | A | 128.18 | 1,285 | 164,711 | 1,285 |